Weyer, C.

Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts Type II diabetes independent of insulin resistance

Weyer, C., Foley, J. E., Bogardus, C., Tataranni, P. A., & Pratley, R. E. (2000) · Diabetologia

Adipokines, Inflammation, and Metabolic DiseasesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 799

Amylin replacement with pramlintide as an adjunct to insulin therapy improves long‐term glycaemic and weight control in Type 1 diabetes mellitus: a 1‐year, randomized controlled trial

Ratner, R. E., Dickey, R., Fineman, M., Maggs, D. G., Shen, L., Strobel, S. A., Weyer, C., & Kolterman, O. G. (2004) · Diabetic Medicine

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 307

Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance.

Weyer, C., Bogardus, C., & Pratley, R. E. (1999) · Diabetes

Pancreatic function and diabetesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 292

Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes

Chapman, I., Parker, B., Doran, S., Feinle-Bisset, C., Wishart, J., Strobel, S., Wang, Y., Burns, C., Lush, C., Weyer, C., et al. (2005) · Diabetologia

Regulation of Appetite and ObesityDiabetes Treatment and Management

Cited by 205

Determinants of energy expenditure and fuel utilization in man: effects of body composition, age, sex, ethnicity and glucose tolerance in 916 subjects

Weyer, C., Snitker, S., Rising, R., Bogardus, C., & Ravussin, E. (1999) · International Journal of Obesity

Body Composition Measurement TechniquesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 196

Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans.

Weyer, C., Tataranni, P. A., Snitker, S., Danforth, E., & Ravussin, E. (1998) · Diabetes

Adipose Tissue and MetabolismAdipokines, Inflammation, and Metabolic Diseases

Cited by 188

The human amylin analog, pramlintide, corrects postprandial hyperglucagonemia in patients with type 1 diabetes

Fineman, M. S., Koda, J. E., Shen, L. Z., Strobel, S. A., Maggs, D. G., Weyer, C., & Kolterman, O. G. (2002) · Metabolism

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 129

Changes in energy metabolism in response to 48 h of overfeeding and fasting in Caucasians and Pima Indians

Weyer, C., Vozarova, B., Ravussin, E., & Tataranni, P. (2001) · International Journal of Obesity

Dietary Effects on HealthRegulation of Appetite and Obesity

Cited by 91

Exaggerated insulin secretion in Pima Indians and African-Americans but higher insulin resistance in Pima Indians compared to African-Americans and Caucasians

Stefan, N., Stumvoll, M., Weyer, C., Bogardus, C., Tataranni, P. A., & Pratley, R. E. (2004) · Diabetic Medicine

Pancreatic function and diabetesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 44